BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12192200)

  • 1. Determination of thiopurine methyltransferase genotype or phenotype optimizes initial dosing of azathioprine for the treatment of Crohn's disease.
    Regueiro M; Mardini H
    J Clin Gastroenterol; 2002 Sep; 35(3):240-4. PubMed ID: 12192200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NUDT15 variant is the most common variant associated with thiopurine-induced early leukopenia and alopecia in Korean pediatric patients with Crohn's disease.
    Lee YJ; Hwang EH; Park JH; Shin JH; Kang B; Kim SY
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):475-8. PubMed ID: 26735160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy.
    Colombel JF; Ferrari N; Debuysere H; Marteau P; Gendre JP; Bonaz B; Soulé JC; Modigliani R; Touze Y; Catala P; Libersa C; Broly F
    Gastroenterology; 2000 Jun; 118(6):1025-30. PubMed ID: 10833476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choice of azathioprine or 6-mercaptopurine dose based on thiopurine methyltransferase (TPMT) activity to avoid myelosuppression. A prospective study.
    Gisbert JP; Luna M; Maté J; González-Guijarro L; Cara C; Pajares JM
    Hepatogastroenterology; 2006; 53(69):399-404. PubMed ID: 16795981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.
    Coenen MJ; de Jong DJ; van Marrewijk CJ; Derijks LJ; Vermeulen SH; Wong DR; Klungel OH; Verbeek AL; Hooymans PM; Peters WH; te Morsche RH; Newman WG; Scheffer H; Guchelaar HJ; Franke B;
    Gastroenterology; 2015 Oct; 149(4):907-17.e7. PubMed ID: 26072396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression.
    Zelinkova Z; Derijks LJ; Stokkers PC; Vogels EW; van Kampen AH; Curvers WL; Cohn D; van Deventer SJ; Hommes DW
    Clin Gastroenterol Hepatol; 2006 Jan; 4(1):44-9. PubMed ID: 16431304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of thiopurine methyltransferase status with azathioprine side effects in Chinese patients with systemic lupus erythematosus.
    Chen D; Lian F; Yuan S; Wang Y; Zhan Z; Ye Y; Qiu Q; Xu H; Liang L; Yang X
    Clin Rheumatol; 2014 Apr; 33(4):499-503. PubMed ID: 24322830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of thiopurine methyltransferase enzyme testing in inflammatory bowel disease.
    Chisick L; Oleschuk C; Bernstein CN
    Can J Gastroenterol; 2013 Jan; 27(1):39-43. PubMed ID: 23378982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of red blood cell 6-thioguanine nucleotide is beneficial in azathioprine maintenance therapy of Chinese Crohn's disease patients.
    Liu Q; Wang Y; Mei Q; Han W; Hu J; Hu N
    Scand J Gastroenterol; 2016 Sep; 51(9):1093-9. PubMed ID: 27152547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients.
    Kurzawski M; Dziewanowski K; Gawrońska-Szklarz B; Domański L; Droździk M
    Ther Drug Monit; 2005 Aug; 27(4):435-41. PubMed ID: 16044099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription.
    Fargher EA; Tricker K; Newman W; Elliott R; Roberts SA; Shaffer JL; Bruce I; Payne K
    J Clin Pharm Ther; 2007 Apr; 32(2):187-95. PubMed ID: 17381669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiating azathioprine for Crohn's disease.
    Levesque BG; Loftus EV
    Clin Gastroenterol Hepatol; 2012 May; 10(5):460-5. PubMed ID: 22330233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
    Dilger K; Schaeffeler E; Lukas M; Strauch U; Herfarth H; Müller R; Schwab M
    Ther Drug Monit; 2007 Feb; 29(1):1-5. PubMed ID: 17304143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
    Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
    J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological monitoring of azathioprine therapy.
    Reuther LO; Sonne J; Larsen NE; Larsen B; Christensen S; Rasmussen SN; Tofteng F; Haaber A; Johansen N; Kjeldsen J; Schmiegelow K
    Scand J Gastroenterol; 2003 Sep; 38(9):972-7. PubMed ID: 14531535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Optimising azathioprine treatment: determination of thiopurine methyltransferase activity and thiopurine metabolites].
    Alvarez Beltran M; Infante Pina D; Tormo Carnicé R; Segarra Cantón O; Redecillas Ferreiro S
    An Pediatr (Barc); 2009 Feb; 70(2):126-31. PubMed ID: 19217567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukopenia due to parvovirus B19 in a Crohn's disease patient using azathioprine.
    van Asseldonk DP; Kanis BM; de Boer NK; van Bodegraven AA
    Digestion; 2009; 79(4):211-4. PubMed ID: 19390192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis.
    Hibi T; Naganuma M; Kitahora T; Kinjyo F; Shimoyama T
    J Gastroenterol; 2003; 38(8):740-6. PubMed ID: 14505127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safe treatment of thiopurine S-methyltransferase deficient Crohn's disease patients with azathioprine.
    Kaskas BA; Louis E; Hindorf U; Schaeffeler E; Deflandre J; Graepler F; Schmiegelow K; Gregor M; Zanger UM; Eichelbaum M; Schwab M
    Gut; 2003 Jan; 52(1):140-2. PubMed ID: 12477776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiopurines in the Management of Crohn's Disease: Safety and Efficacy Profile in Patients with Normal TPMT Activity-A Retrospective Study.
    Benmassaoud A; Xie X; AlYafi M; Theoret Y; Bitton A; Afif W; Bessissow T
    Can J Gastroenterol Hepatol; 2016; 2016():1034834. PubMed ID: 27446822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.